Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.

No Thumbnail Available
Authors
Jones-Hughes, T
Snowsill, T.
Haasova, Marcela
Coelho, H
Crathorne, L.
Cooper, C
Mujica-Mota, R.
Peters, J
Varley-Campbell, J.
Huxley, N.
Journal
Health Technology Assessment
Type
Meta-Analysis
Publisher
NIHR
Rights
Archived with thanks to Health technology assessment (Winchester, England)
End-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation, followed by immunosuppressive therapy (induction and maintenance therapy) to reduce the risk of kidney rejection and prolong graft survival.
Citation
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 2016, 20 (62):1-594 Health Technol Assess
Note
This article is freely available. Click on the 'Additional Link' above to access the full-text.